Restorative gene therapy approaches to Parkinson's disease

Medical Clinics of North America

Volumn 83, Issue 2, 1999, Pages 537-548

  Freese, A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; CELL IMMORTALIZATION; CLINICAL RESEARCH; DOPAMINERGIC SYSTEM; DRUG MECHANISM; DRUG RECEPTOR BINDING; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS 1; IN VIVO STUDY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; REVIEW; TREATMENT PLANNING;

EID: 0033058906     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70119-X     Document Type: Article

References (55)

1. S. Akli C. Caillaud E. Vigne Transfer of a foreign gene into the brain using adenovirus vectors Nat Genet 3 1993 221 228
2. G. Bajocchi S.H. Feldman R.G. Crystal Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors Nat Genet 3 1993 229 234
3. J.R. Baringer P. Sworeland Recovery of herpes-simplex virus from human trigeminal ganglions N Engl J Med 228 1973 9593 9596
4. M.L. Cook U.B. Bastone J.G. Stevens Evidence that neurons harbor latent herpes simplex virus Infect Immun 9 1974 946 951
5. B.L. Davidson E.D. Allen K.F. Kozarsky A model system for in vivo gene transfer into the central nervous system using an adenoviral vector Nat Genet 3 1993 219 223
6. M.J. During D. Choi-Lundberg P. Leone Neuroprotection and neuroregeneration in rodent and primate parkinsonian models using an AAV vector expressing GDNF Abstr Soc Neurosci 21 1995 225.9
7. M.J. During P. Leone Targets for gene therapy of Parkinson's disease: Growth factors, signal transduction, and promoters Exp Neurol 144 1997 74 81
8. M.J. During J.R. Naegele K.L. O'Malley Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase Science 266 1994 1399 1403
9. M.J. During R.J. Samulski J.D. Elsworth In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector Gene Ther 5 1998 820 827
10. Freese A. Gene therapy for Parkinson's disease: Rationale, prospects and limitations Exp Neurol vol 144 1997
11. A. Freese M.J. During K. O'Malley Expression of tyrosine hydroxylase in striatal cells with a HSV-1 vector causes stable production and regulated release of dopa and dopamine: Potential gene therapy for Parkinson's disease Abstr Soc Neurosci 17 1991 424.15
12. A. Freese A.I. Geller Infection of cultured striatal neurons with a defective HSV-1 vector: Implications for gene therapy Nucl Acids Res 19 1991 7219 7223
13. A. Freese M.G. Kaplitt M.J. O'Connor Direct gene transfer into human epileptogenic hippocampal tissue with an adeno-associated virus vector: Implications for a gene therapy approach to epilepsy Epilepsia 38 1997 759 766
14. A. Freese R. Neve A.I. Geller HSV-1 vector-mediated neuronal gene delivery: Strategies for neuroscience and neurology Biochem Pharm 40 1990 2189 2199
15. A. Freese M. Stern M.G. Kaplitt Prospects for gene therapy in Parkinson's disease Mov Disord 11 1996 469 488
16. D.M. Frim T.A. Uhler W.R. Galpern Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridium toxicity to dopamine neurons in the rat Proc Natl Acad Sci U S A 91 1994 5104 5108
17. A.I. Geller X.O. Breakefield A defective HSV-1 vector expresses Escherichia coli B-galactosidase in cultured peripheral neurons Science 241 1988 1667 1669
18. A.I. Geller M.J. During J.W. Haycock Long term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector Proc Natl Acad Sci U S A 90 1993 7603 7607
19. A.I. Geller M.J. During R.L. Neve Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors Trends Neurosci 14 1991 428 432
20. A.I. Geller A. Freese Transfection of cultured central nervous system neurons with a defective HSV-1 vector which expresses B-galactosidase Proc Natl Acad Sci U S A 87 1990 1149 1153
21. A. Geller S. Song F. Lim A helper virus-free packaging system for HSV-1 plasmid vectors that supports efficient gene transfer in the rat brain Abstr Soc Neurosci 21 1995 330.1
22. J.C. Glorioso W.F. Goins C.A. Meaney Gene transfer to brain using herpes simplex virus vectors Ann Neurol 35 1994 28 34
23. Hofer M.M. Barde Y.-A. Brain-derived neurotrophic factor prevents neuronal death in vivo Nature 331 1988 261 262
24. Horrelou P, Sabate O, Buc-Caron M-H, et al: In vivo and ex vivo gene therapy in a rat model of Parkinson's disease. Proceedings of the International Conference on Gene Therapy for CNS Disorders, Philadelphia, 1996, p 3.15
25. P. Horrelou E. Vigne Castel M.-N. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease Neuroreport 6 1994 49 53
26. Jacoby DR, Breakefield XO, Latchman DS: Construction of an HSV-1 amplicon with an inducible Oct-2 operon to modulate cytopathic effect. Proceedings of the International Conference on Gene Therapy for CNS Disorders, Philadelphia, 1996, p 1.31
27. S. Jiao V. Gurevich J.A. Wolff Long-term correction of a rat model of Parkinson's disease by gene therapy Nature 362 1993 450 453
28. S. Jiao E. Schultz J.A. Wolff Intracerebral transplants of primary muscle cells: A potential ‘platform’ for transgene expression in the brain Brain Res 575 1992 143 147
29. S. Jiao J.A. Wolff Long-term survival of autologous muscle grafts in rat brain Neurosci Lett 137 1992 207 210
30. Kang UJ, Benecsics C, Cahill AL, et al: Regulation of l -dopa production by 5,6,7,8-tetrahydro-L-biopterin in genetically modified cells. Proceedings of the International Conference on Gene Therapy for CNS Disorders, Philadelphia, 1996, p 3.11
31. M.G. Kaplitt P. Leone R.J. Samulski Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain Nat Genet 8 1994 148 154
32. M.D. Kawaja F.H. Gage Morphological and neurochemical features of cultured primary skin fibroblasts of Fischer 344 rats following striatal implantation J Comp Neurol 317 1992 102 116
33. D. Kwong N. Frenkel The herpes simplex virus virion host shutoff function J Virol 63 1989 487 496
34. Le Gal La Salle G. J.J. Robert An adenovirus vector for gene transfer into neurons and glia in the brain Science 259 1993 988 990
35. Lin L.-F.H. D.H. Doherty J.D. Lile GDNF: A glial cell-line derived neurotrophic factor for midbrain dopaminergic neurons Science 260 1993 1130 1132
36. O. Lin D.L. Choi-Lundberg J. Ravenell Adenoviral (Ad)-mediated gene transfer of GDNF and B-galactosidase (lac Z) to the rat nigrostriatal system in vitro and in vivo Abstr Soc Neurosci 21 1995 224.12
37. R.M. Lindsay Neuron saving schemes Nature 273 1995 289 290
38. M.J. Lysaght B. Frydel F. Gentile Recent progress in immunoisolated cell therapy J Cell Biochem 56 1994 196 203
39. R.L. Martuza A. Malick J.M. Markert Experimental therapy of human glioma by means of a genetically engineered virus mutant Science 252 1991 854 856
40. Morassutti DJ, Atasoy E, Staines WA, et al: Characterization of murine P19 EC-derived neurons expressing foreign rat TH cDNA-in vitro and in vivo. Proceedings of the International Conference on Gene Therapy for CNS Disorders, Philadelphia, 1995, p 3.12
41. N. Muzyczka Use of adeno-associated virus as a general transduction vector for mammalian cells Curr Top Microbiol Immunol 158 1992 97 129
42. K. O'Malley A.I. Geller Gene therapy in neurology: Potential application to Parkinson's disease Vecsei L. Freese E. Swartz K.J. Neurological Disorders: Novel Experimental and Therapeutic Strategies 1992 Ellis Horwood Limited West Sussex 223 248
43. T.D. Palella Y. Hidaka L.J. Silverman Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vector Gene 80 1989 137 144
44. T.D. Palmer G.J. Rosman W.R.A. Osborne Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes Proc Natl Acad Sci U S A 88 1991 1330 1334
45. J. Ray F.H. Gage Gene transfer into established and primary fibroblast cell lines: Comparison of transfection methods and promoters Biotechniques 13 1992 598 603
46. H.K. Raymon S. Thode F.H. Gage Application of ex vivo gene therapy in the treatment of Parkinson's disease Exp Neurol 144 1997 82 91
47. Samulski R.J. Chang L.-S. T. Shenk Helper-free stocks of adeno-associated viruses: Normal integration does not require viral gene expression J Virol 63 1989 3822 3828
48. R. Scharfmann J.H. Axelrod I.M. Verma Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants Proc Natl Acad Sci U S A 88 1991 4626 4630
49. R.R. Spaete N. Frenkel The herpes simplex virus amplicon: A new eucaryotic defective virus cloning-amplifying vector Cell 30 1982 295 304
50. M.B. Stern A. Freese Parkinson's disease: The case for novel treatment strategies Exp Neurol 144 1997 2 3
51. A. Tomac E. Lindqvist Lin L.-F.H. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo Nature 373 1995 335 339
52. K. Uchida A. Ishii N. Kaneda Tetrahydrobiopterin-dependent production of l -dopa in NRK fibroblasts transfected with tyrosine hydroxylase cDNA: Future use for intracerebral grafting Neurosci Lett 109 1990 282 286
53. D.A. Vlazny N. Frenkel Replication of herpes simplex virus DNA: Localization of replication recognition signals within defective virus genomes Proc Natl Acad Sci U S A 78 1981 742 746
54. D.A. Vlazny A. Kwong N. Frenkel Site-specific cleavage/packaging of herpes simplex virus DNA and the selective maturation of nucleocapsids containing full-length viral DNA Proc Natl Acad Sci U S A 79 1979 1423 1427
55. J.A. Wolff L.J. Fisher L. Xu Grafting fibroblasts genetically modified to produce l -dopa in a rat model of Parkinson disease Proc Natl Acad Sci U S A 86 1989 9011 9014